tretinoin 0.5 MG/ML Topical Lotion [Altreno]
- RxCUI
- 2055008
- RxNorm name
- tretinoin 0.5 MG/ML Topical Lotion [Altreno]
- Display name
- ALTRENO (Topical)
- Full name
- tretinoin 0.5 MG/ML Topical Lotion [Altreno]
- Term type
- SBD
- Status
- Active
- Strength
- 0.05%
- Dose form
- Lotion
- Route
- Topical
- Updated
- 2026-11-08 10:06:24
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102018
- Active start
- 102018
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| tretinoin | 0.5 MG / 1 ML | tretinoin | tretinoin |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Lotion | 316983 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tretinoin | 10753 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Altreno 0.05 % Topical Lotion | 1 | NAMES |
| RxNorm Name | tretinoin 0.5 MG/ML Topical Lotion [Altreno] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 1412aba5-71aa-4cce-8db4-c189bed1852c | 1 | CODES |
| RxCUI | 2055008 | 1 | CODES |
| MMSL_CODE | BD33837 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0187-0005-03 | 0187-0005 | Altreno tretinoin | Bausch Health US, LLC | NDA209353 |
| 0187-0005-10 | 0187-0005 | Altreno tretinoin | Bausch Health US, LLC | NDA209353 |
| 0187-0005-20 | 0187-0005 | Altreno tretinoin | Bausch Health US, LLC | NDA209353 |
| 0187-0005-45 | 0187-0005 | Altreno tretinoin | Bausch Health US, LLC | NDA209353 |
| 0187-0005-50 | 0187-0005 | Altreno tretinoin | Bausch Health US, LLC | NDA209353 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Altreno | TRETINOIN | Bausch Health US, LLC | 1412aba5-71aa-4cce-8db4-c189bed1852c | 2026-10-14 | Warnings, Adverse reactions | 0187-0005-20 0187-0005-50 0187-0005-10 0187-0005-03 0187-0005-45 0187-0005 00187000545 00187000520 00187000550 00187000503 00187000504 00187000510 2055008 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1412aba5-71aa-4cce-8db4-c189bed1852c | Altreno 0.05 % Topical Lotion [PSN] · tretinoin 0.5 MG/ML Topical Lotion [Altreno] [SBD] · Altreno 0.05 % Topical Lotion [SY] · Altreno 0.5 MG/ML Topical Lotion [SY] | 4 | 16 | These highlights do not include all the information needed to use ALTRENO safely and effectively. See full prescribing information for ALTRENO. ALTRENO ® (tretinoin) lotion, for topical use Initial U.S. Approval: 1973 | 20200302 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 1412aba5-71aa-4cce-8db4-c189bed1852c | These highlights do not include all the information needed to use ALTRENO safely and effectively. See full prescribing information for ALTRENO. ALTRENO ® (tretinoin) Lotion, for topical use Initial U.S. Approval: 1973 | Bausch Health US, LLC | Bausch Health Companies Inc. | 20261014 |
| 1412aba5-71aa-4cce-8db4-c189bed1852c | These highlights do not include all the information needed to use ALTRENO safely and effectively. See full prescribing information for ALTRENO. ALTRENO ® (tretinoin) lotion, for topical use Initial U.S. Approval: 1973 | Bausch Health US, LLC | Bausch Health Companies Inc. | 20200302 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | L01XF | Retinoids for cancer treatment | ATC1-4 | tretinoin | |
| ATC | D10AD | Retinoids for topical use in acne | ATC1-4 | tretinoin | |
| FDASPL | D012176 | Retinoids | CHEM | has_chemical_structure | tretinoin |
| FDASPL | N0000175607 | Retinoid | EPC | has_epc | tretinoin |
| MEDRT | D010226 | Parabens | CHEM | ci_chemclass | tretinoin |
| MEDRT | D014212 | Tretinoin | CHEM | has_ingredient | tretinoin |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | tretinoin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | tretinoin |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | tretinoin |
| MEDRT | D017495 | Hyperpigmentation | DISEASE | may_treat | tretinoin |
| MEDRT | D015473 | Leukemia, Promyelocytic, Acute | DISEASE | may_treat | tretinoin |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | tretinoin |
| MEDRT | N0000000085 | Receptor Interactions | MOA | has_moa | tretinoin |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | tretinoin |
| MEDRT | N0000175676 | Decreased Epithelial Proliferation | PE | has_pe | tretinoin |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | tretinoin |
| MEDRT | N0000009979 | Decreased Sebaceous Gland Quantity | PE | has_pe | tretinoin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA209353 |
| NAMES | Prescribable Synonym | Altreno 0.05 % Topical Lotion |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |